Fauci's New Gig; Secret World of Penile Enlargement; Malaria Cases Emerge in U.S. Health news and commentary from around the Web gathered by staff Jun 27, 2023
Shorter Antibiotic Course Not as Effective for Children With UTIs But despite more treatment failure, short-course therapy suggested as a "reasonable option" Jun 26, 2023
Another Online SARMs Retailer Gets a Warning From the FDA Warrior Labz SARMS markets several drugs they claim could address weight loss, muscle growth Jun 22, 2023
Massive Kidney Stone Sets New Record Surgeons in Sri Lanka removed the record-setting stone earlier this month Jun 21, 2023
Cystic Renal Masses Often Harbor High-Grade Disease No link between grade and cancer-specific survival, active surveillance still an option for many Jun 16, 2023
No Increase in Major Cardiac Events With Testosterone-Replacement Therapy Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo Jun 16, 2023
FDA OKs Over-the-Counter Gel for Erectile Dysfunction Nonprescription topical showed 10-minute onset of action in clinical trials Jun 12, 2023
Airlines Need to Let Wheelchair Users Use Them on Planes, AMA Members Say Rescheduling testosterone also under discussion at annual meeting Jun 12, 2023
AMA Urged to Do More to Safeguard Adolescent Gender-Affirming Care Association needs to move from passive support to proactive protection, delegate says Jun 11, 2023
States Must Stop Criminalizing Medicine, AMA Delegates Say "This is unacceptable...and it's time for us to push back" Jun 11, 2023
FGFR Inhibitor Stakes Claim to Post-Anti-PD-1 Role in Advanced Bladder Cancer Survival benefit supports FGFR testing for all patients with metastatic disease, researcher says Jun 07, 2023
FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer Approval limited to BRCA-positive subset Jun 01, 2023
'Practice Changing' Trial on Activity Recs After Prolapse Surgery In randomized study, noninferior outcomes for expedited activity versus standard wait of 6 weeks May 31, 2023
Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
Tainted 'Male Enhancement' Pills; Green Card Freeze Hits Nursing; Monkeypox Rebounds Health news and commentary from around the Web gathered by staff May 15, 2023
The Patient Case Against Requiring Medical Chaperones What sounds good in theory falls short in practice May 07, 2023
Snipless Vasectomy Shows Early Promise as Long-Term Male Contraceptive Hydrogel occlusion of vas achieves azoospermia quickly, maintained for a month May 03, 2023
Platelet-Rich Plasma Injections Flop for Erectile Dysfunction in U.S. Study Results from randomized trial contradict those seen in two European studies May 02, 2023
Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer Two studies suggest no harm from deferred cytoreduction, potential benefits of immunotherapy May 02, 2023
Sublingual Vaccine Shows Promise in Women With Recurrent UTIs 40% of women who received a 3-month course of MV140 had no UTIs during 9-month follow-up May 01, 2023
More Men Are Expressing Interest in Vasectomy After SCOTUS Abortion Decision Vasectomy consults more than doubled in the 3 months after Dobbs compared with the year before May 01, 2023
Erectile Dysfunction Drugs May Have Major Cardiovascular Benefits PDE5 inhibitors lowered risk of CHF, MI, overall mortality in men with ED and CVD Apr 30, 2023
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by staff Apr 28, 2023
CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
Post-Immunotherapy Combo Promising in Advanced RCC Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
Neuromodulation of the Peroneal Nerve Safe for Overactive Bladder Was also as effective as solifenacin in the majority of assessed efficacy endpoints Mar 24, 2023
Treating Gender Nonconforming Youth Goes Beyond the Physical We must approach care for every patient from the lens of treating the entire individual Mar 15, 2023
Gender-Affirming Surgery Gets a Boost After California Law Kicked In Nondiscrimination law bars insurers from limiting benefits based on gender identity, expression Mar 14, 2023
Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
A Surge in Vasectomies: Sustaining the Demand To increase participation, let's reduce the points of friction Mar 13, 2023
Daily Thiazide No Help in Preventing Recurrent Kidney Stones Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subset Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuria Non-immunosuppressive therapy led to 50% reduction in proteinuria Feb 21, 2023
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
